Drug Profile
Influenza A virus H5N1 vaccine - Denka Seiken
Alternative Names: A-04-01DLatest Information Update: 25 Nov 2015
Price :
$50
*
At a glance
- Originator Denka Seiken
- Class Influenza A virus H5N1 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza A virus H5N1 subtype
Most Recent Events
- 25 Nov 2015 No recent reports on development identified - Phase-II/III for Influenza-A virus H5N1 subtype (Prevention) in Japan (IM)